• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Akorn Pharmaceuticals - Articles and news items

Allergan receives Paragraph IV notification on Restasis

Industry news / 16 July 2015 / Victoria White

Akorn Pharmaceuticals seeks approval to market a generic version of Allergan’s Restasis from the US Food and Drug Administration FDA…


Webinar: SIFT-MS: A New Tool for Impurity Profiling in Pharmaceutical ProductsLEARN MORE
+ +